Decibel Cannabis Company Inc. (CVE:DB) faces challenges as analysts downgrade their revenue forecasts for the current year. Following a significant reduction in expected revenue, the consensus estimate for Decibel’s revenue has been adjusted to CA$104 million for 2025, reflecting a 12% increase compared to sales over the past year. This adjustment marks a stark decline from previous estimates, which projected revenues of CA$121 million and earnings per share (EPS) of CA$0.02 for the same period.
The analysts’ revisions indicate a notable shift in sentiment, highlighting concerns over the company’s growth trajectory. The expected EPS is now projected to hover around break-even, suggesting that business conditions may not improve as previously anticipated.
Despite this downturn, Decibel Cannabis is poised to outpace the broader market, with a projected 17% annualized growth rate until 2025, significantly higher than the average 5.6% growth forecast for other companies in the cannabis sector.
The consensus price target for Decibel Cannabis has also been lowered by 16%, now set at CA$0.23. This adjustment reflects the analysts’ reduced optimism regarding the company’s future valuation.
As market forces weigh on Decibel Cannabis, investors may reconsider their positions in light of the revised forecasts. While the company is still expected to grow, the pace of that growth appears to be slowing, raising questions about its ability to maintain momentum in a competitive industry.
English 
Spanish 
German 
Czech